Cargando…

Role of diet in prostate cancer: the epigenetic link

Diet is hypothesized to be a critical environmentally related risk factor for prostate cancer (PCa) development, and specific diets and dietary components can also affect PCa progression; however, the mechanisms underlying these associations remain elusive. As for a maturing organism, PCa's epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labbé, D P, Zadra, G, Ebot, E M, Mucci, L A, Kantoff, P W, Loda, M, Brown, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476943/ https://www.ncbi.nlm.nih.gov/pubmed/25531313 http://dx.doi.org/10.1038/onc.2014.422

Ejemplares similares

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
por: Labbé, David P., et al.
Publicado: (2019)

When fat goes down, prostate cancer is on the ropes
por: Zadra, Giorgia, et al.
Publicado: (2019)

The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
por: Kelly, Rachel S., et al.
Publicado: (2016)

Transcriptional landscape of PTEN loss in primary prostate cancer
por: Imada, Eddie Luidy, et al.
Publicado: (2021)

Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss
por: Bastos, Débora C, et al.
Publicado: (2020)

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels
por: Jesser, C, et al.
Publicado: (2008)

Polycomb-independent activity of EZH2 in castration resistant prostate cancer
por: Xu, Kexin, et al.
Publicado: (2013)

Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases
por: De Piano, Mario, et al.
Publicado: (2020)

Epigenetics in Prostate Cancer
por: Albany, Costantine, et al.
Publicado: (2011)

Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2010)

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021)

Linking African ancestral substructure to prostate cancer health disparities
por: Gheybi, Kazzem, et al.
Publicado: (2023)

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T
por: Small, E J, et al.
Publicado: (2014)

Epigenetic regulation of prostate cancer
por: Chin, Suyin P., et al.
Publicado: (2011)

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
por: Zadra, Giorgia, et al.
Publicado: (2014)

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
por: Zadra, Giorgia, et al.
Publicado: (2014)

Prostate Cancer Progression: as a Matter of Fats
por: Scaglia, Natalia, et al.
Publicado: (2021)

A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
por: Dickerman, Barbra A., et al.
Publicado: (2020)

Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression
por: Graff, Rebecca E, et al.
Publicado: (2016)

Lactate as Key Metabolite in Prostate Cancer Progression: What Are the Clinical Implications?
por: Chetta, Paolo, et al.
Publicado: (2023)

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015)

The association of diabetes with risk of prostate cancer defined by clinical and molecular features
por: Feng, Xiaoshuang, et al.
Publicado: (2020)

Epigenetic and Epitranscriptomic Control in Prostate Cancer
por: López, Judith, et al.
Publicado: (2022)

Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015)

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
por: Cejas, Paloma, et al.
Publicado: (2021)

Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
por: Camilo, Vânia, et al.
Publicado: (2023)

Epigenetic Mechanisms Link Maternal Diets and Gut Microbiome to Obesity in the Offspring
por: Li, Yuanyuan
Publicado: (2018)

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
por: Qiu, Xintao, et al.
Publicado: (2022)

A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research
por: Laccetti, Andrew L, et al.
Publicado: (2020)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
por: Braunstein, Lior Z., et al.
Publicado: (2014)

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
por: Bosutti, Alessandra, et al.
Publicado: (2016)

Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays
por: Stopsack, Konrad H, et al.
Publicado: (2021)

Epigenetic regulation of prostate cancer
por: Wang, Ruixin, et al.
Publicado: (2019)

Epigenetics in prostate cancer treatment
por: Jones, Katelyn, et al.
Publicado: (2021)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
por: Storck, William K., et al.
Publicado: (2022)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
por: Gui, Bin, et al.
Publicado: (2017)

Diet and Transgenerational Epigenetic Inheritance of Breast Cancer: The Role of the Paternal Germline
por: da Cruz, Raquel Santana, et al.
Publicado: (2020)

Virus linked with prostate cancer
por: Powledge, Tabitha M
Publicado: (2006)

A case-control study of diet and prostate cancer.
por: Key, T. J., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_bg5hipujvo87r7e2qvjsf76olv